Obesity as a Risk Factor for Alzheimer’s Disease: Implication of Leptin and Glutamate

por Lloret, Ana, Monllor, Paloma, Esteve, Daniel, Cervera-Ferri, Ana, Lloret, Maria-Angeles
Publicado 2019

Is Sleep Disruption a Cause or Consequence of Alzheimer’s Disease? Reviewing Its Possible Role as a Biomarker

por Lloret, Maria-Angeles, Cervera-Ferri, Ana, Nepomuceno, Mariana, Monllor, Paloma, Esteve, Daniel, Lloret, Ana
Publicado 2020

When Does Alzheimer′s Disease Really Start? The Role of Biomarkers

por Lloret, Ana, Esteve, Daniel, Lloret, Maria-Angeles, Cervera-Ferri, Ana, Lopez, Begoña, Nepomuceno, Mariana, Monllor, Paloma
Publicado 2019

Is Oxidative Stress the Link Between Cerebral Small Vessel Disease, Sleep Disruption, and Oligodendrocyte Dysfunction in the Onset of Alzheimer’s Disease?

por Lloret, Ana, Esteve, Daniel, Lloret, Maria Angeles, Monllor, Paloma, López, Begoña, León, José Luis, Cervera-Ferri, Ana
Publicado 2021

Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?

por Monllor, Paloma, Cervera-Ferri, Ana, Lloret, Maria-Angeles, Esteve, Daniel, Lopez, Begoña, Leon, Jose-Luis, Lloret, Ana
Publicado 2021